Join
Live feed
·
INSIDERFilingvia Quantisnow
Kyverna Therapeutics Inc. logo

Chief Executive Officer Biddle Warner Weston was granted 58,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KYTX· Kyverna Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KYTX (Kyverna Therapeutics Inc.) and more on Quantisnow.